Breaking News
Get 45% Off 0
Selloff or market correction? Either way, here's what to do next
See Overvalued Stocks

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Cancer Space Update: 2 Drugs Receive Regulatory Nod In EU By Zacks Investment Research - Nov 24, 2017

There was not much activity in the U.S. cancer space this week. However, we saw two drugs getting regulatory nod from the European Commission ("EC"). Zejula received approval as monotherapy for the...

Zacks Investment Research
UBS Group Witnesses Bottom-Line Pressure: Time To Sell? By Zacks Investment Research - Nov 24, 2017

UBS Group AG’s (NYSE:UBS) profitability remains under pressure due to prevailing unfavorable interest rates and strict regulations in the domestic economy.The company has witnessed 6.2%...

Zacks Investment Research
GE Signs Contracts In Aviation & Power To Retain Core Focus By Zacks Investment Research - Nov 24, 2017

Industrial goods manufacturer General Electric Company (NYSE:GE) recently inked two new contracts in the Aviation and Power segments in its continued efforts to sustain focus on the core business...

Zacks Investment Research
Forget U.S., International Small-Cap ETFs Are Hitting Highs By Zacks Investment Research - Nov 24, 2017

U.S. small-cap stocks may likely be winners on Trump’s proposed tax cut reforms and economic buoyancy. But uncertainty will linger until Trump’s planned policies see the day of light and...

Zacks Investment Research
Teva (TEVA) Stock Rises 5% On Reports Of Massive Job Cuts By Zacks Investment Research - Nov 24, 2017

According to an Israeli newspaper, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is expected to reduce its workforce by about 4000. Consequently, shares of the company were up by more than 5% in...

Edison
Alkane Resources: The Final Countdown   By Edison - Nov 24, 2017

Alkane Resources (AX:ALK) fourth quarter of CY17 going into Q1 CY18 should prove pivotal to the development of the Dubbo Project (DP), aided in no small part by a strong broad rebound in DP-relevant...

Zacks Investment Research
CAR-T Therapy Space 2017 Progress Report By Zacks Investment Research - Nov 24, 2017

The immuno-oncology space has been in the limelight in 2017. The CAR-T therapy space in particular, has been grabbing investors, courtesy of two key approvals.The FDA’s approval of Novartis...

Modest Money
5 Charts Showing The Health Of The Banking Industry By Modest Money - Nov 24, 2017

The average price-to-earnings ratio of the S&P 500 is now 25, and the cyclically-adjusted price-to-earnings ratio is over 31.But the financial sector’s average price-to-earnings ratio is...

Modest Money
Alibaba Better Than Amazon And More Affordable By Modest Money - Nov 24, 2017

Investors know that Amazon (NASDAQ:AMZN) is hot. They continue to expand into new markets and consistently grow earnings for shareholders. But one thing that holds back some investors, especially...

Zacks Investment Research
Add These 4 Promising Stocks To Your Cyber Monday Cart By Zacks Investment Research - Nov 24, 2017

Black Friday usually offers a galore of shopping deals but Cyber Monday is likely to be more tempting. Bargain hunters are expected to take to the Internet on Cyber Monday (Nov 27), which is...

Zacks Investment Research
Prepare For 2018 With These ETFs By Zacks Investment Research - Nov 24, 2017

Like several other Wall Street analysts, Bank of America Merrill Lynch (NYSE:BAC) also sees an upbeat 2018 for stocks. But this optimism is being felt only for the first half, following which the...

Declan Fallon
Look To NASDAQ, NASDAQ 100 To Be Today's Primary Chargers By Declan Fallon - Nov 24, 2017 1

Thanksgiving Wednesday was never going to generate an exciting day but it was good to see early week gains retained. Upcoming Thanksgiving Friday is typically a day when Junior traders go wild and...

Zacks Investment Research
AdvisorShares' First Vice ETF On The Way By Zacks Investment Research - Nov 23, 2017

With the exponential growth of the ETFs, "thematic investing” is rising and the “smart beta” theme is selling like hot cakes. In order to make the most of this trend, AdvisorShares...

Continue with Apple
Continue with Google
or
Sign up with Email